These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4593243)

  • 41. Immunization with Escherichia coli enterotoxin protects against homologous enterotoxin challenge.
    Sack RB
    Infect Immun; 1973 Oct; 8(4):641-4. PubMed ID: 4582639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccine for enterotoxigenic Escherichia coli based on synthetic heat-stable toxin crossed-linked to the B subunit of heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    J Infect Dis; 1983 Feb; 147(2):318-26. PubMed ID: 6338132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of Vibrio cholerae and Escherichia coli heat-labile enterotoxin by enzyme-linked immunosorbent assay (ELISA).
    Kétyi I; Pácsa AS
    Acta Microbiol Acad Sci Hung; 1980; 27(1):89-97. PubMed ID: 6998259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
    Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
    Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin.
    Cruce DD; Wachsmuth IK; Feeley JC
    Diagn Immunol; 1983; 1(2):87-9. PubMed ID: 6680095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on enterotoxin from Escherichia coli associated with acute diarrhea in man.
    Etkin S; Gorbach SL
    J Lab Clin Med; 1971 Jul; 78(1):81-7. PubMed ID: 4936367
    [No Abstract]   [Full Text] [Related]  

  • 48. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting.
    Bull World Health Organ; 1990; 68(3):303-12. PubMed ID: 2203550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitoxic immunity in cholera and enterotoxigenic Escherichia coli (ETEC) diarrhea.
    DuPont HL; Evans DG; Evans DJ; Satterwhite TK
    Pharmacol Ther; 1981; 13(2):249-55. PubMed ID: 7025036
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay.
    Evans DG; Evans DJ; Gorbach SL
    Infect Immun; 1973 Nov; 8(5):731-5. PubMed ID: 4584049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural antibodies in healthy adults.
    Veres J
    Acta Microbiol Acad Sci Hung; 1975; 22(2):65-73. PubMed ID: 235827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.
    Chen WH; Garza J; Choquette M; Hawkins J; Hoeper A; Bernstein DI; Cohen MB
    Clin Vaccine Immunol; 2015 Jan; 22(1):129-35. PubMed ID: 25410205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serologic cross reactivity of some Escherichia coli strains with cholera vibrios.
    Năcescu N; Ciufecu C; Trifan G; Barabaş E
    Arch Roum Pathol Exp Microbiol; 1974 Mar; 33(1):23-6. PubMed ID: 4597315
    [No Abstract]   [Full Text] [Related]  

  • 54. LT antitoxin titres in three-week-old, E. coli-vaccinated pigs.
    Semjén G; Pesti L
    Acta Vet Acad Sci Hung; 1981; 28(3):269-71. PubMed ID: 7020382
    [No Abstract]   [Full Text] [Related]  

  • 55. The modulating effect of cholera enterotoxin on the immune response.
    Chisari FV; Northrup RS; Chen LC
    J Immunol; 1974 Sep; 113(3):729-39. PubMed ID: 4370486
    [No Abstract]   [Full Text] [Related]  

  • 56. Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona.
    Sack RB; Hirschborn N; Woodward WE; Sack DA; Cash RA
    Infect Immun; 1975 Dec; 12(6):1475-7. PubMed ID: 1107221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. E. coli heat-labile (LT) antitoxin levels in pigs and in E. coli-vaccinated sows.
    Pesti L; Semjén G
    Acta Vet Acad Sci Hung; 1980; 28(1):13-20. PubMed ID: 7018204
    [No Abstract]   [Full Text] [Related]  

  • 60. Antigen-extinction profile in pregnant cows, using a K99-containing whole-cell bacterin to induce passive protection against enterotoxigenic colibacillosis of calves.
    Acres SD; Forman AJ; Kapitany RA
    Am J Vet Res; 1982 Apr; 43(4):569-75. PubMed ID: 7041714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.